European Union Recommended NAION Warnings In June 2025, the European Medicines Agency (EMA) recommended updating the labeling for semaglutide to list NAION as a very rare side effect, affecting up to 1 in 10,000 users
In order to best prepare and handle peptides in solution, its important to understand all aspects of using bacteriostatic water solutions
Why does weight loss affect estrogen and ovulation
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic A et al (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
The formula is presented as non-GMO and gluten free, and it is manufactured in a GMP compliant, FDA registered facility